Indian markets traded volatile after Monday’s decline and settled marginally lower on Tuesday amid mixed signals. In today’s trade, shares of Pidilite, Godrej Consumer, PB Fintech, Gland Pharma, Tata Power among others will be in focus due to various news developments and first quarter results. Pidilite, Godrej Consumer, NHPC, BSE, ABFRL Shares of Pidilite, Godrej … Read more
Jun 16, 2024, 12:31:07 PM IST Around seven mutual funds exited from 18 stocks in their portfolio in May. Here is the breakdown of the stocks exited, according to Mutual Fund Insight by Nuvama Alternative & Quantitative Research. iStock HDFC Mutual Fund made a complete exit from Radico Khaitan, Phoenix Mills, and Sundaram Finance. The … Read more
Hospital stocks fell up to 11% on Friday, witnessing their second successive decline following the Supreme Court’s diktat on cost rationalisation. The biggest loser on an intraday basis was Max Healthcare Institute which hit the day’s low of Rs 706.45 on the NSE. It was followed by Yatharth Hospital & Trauma Care Services which plunged … Read more
Benchmark indices rebounded nearly 1% on Tuesday following positive global trends. The 30-share Sensex climbed 454 points to settle at 72,186 and the Nifty gained 157 points to close at 21,929. Stocks that were in focus included names like YES Bank, which rose 11.62%, PB Fintech, which fell 6.15%, and Fortis Healthcare, whose shares increased … Read more
Brokerage Nomura maintained a buy rating on Fortis Healthcare, ICICI Securities initiated a buy on Cello World, Morgan Stanley maintained a positive view on HPCL and Emkay has a positive view on Emami. We have collated a list of recommendations from top brokerage firms from ETNow and other sources: Nomura on Fortis Healthcare: Buy| Target … Read more
